Medscape HIV/AIDS Headlines

FDA Safety Changes: DepoDur, Neoral, Lexiva

Wed, 4 Nov 2009 12:14:25 EST

The FDA has approved safety labeling revisions for morphine sulfate extended-release liposome injection, cyclosporine capsules and oral solution, and fosamprenavir calcium tablets and oral suspension.
Medscape Medical News

Physicians Are Talking About: A Death Foretold

Wed, 4 Nov 2009 11:14:29 EST

Would you operate on a patient who experienced a premonition of death? Is this a contraindication surgery? Medscape Physician Connect members discuss whether to ignore or heed premonitions.
Medscape Family Medicine

Ezetimibe Improves Cholesterol Control in HIV Patients

Wed, 4 Nov 2009 13:33:31 EST

Addition of ezetimibe to ongoing statin therapy prompts improvement in lipid levels in patients with HIV, researchers report in the October 23rd issue of AIDS.
Reuters Health Information

Dose Reduction May Prevent Efavirenz Discontinuation in HIV Patients

Mon, 2 Nov 2009 12:52:37 EST

Efavirenz dose reduction is safe in HIV patients with high plasma concentrations and may prevent toxicity-induced discontinuations, Dutch researchers report in the October 1st issue of the Journal of Acquired Immune Deficiency Syndromes.
Reuters Health Information